Phase 1a Safety and Pharmacokinetics (PK) of ABI-H0731, a Novel Core Protein Allosteric Modifier (CpAM) For The Treatment of Chronic HBV InfectionEdward J. Gane,Christian Schwabe,Sandy Liaw,Eric Ruby,Leping Li,Kelvin Chan,Kashyap Patel,Patrick Smith,Richard Colonno,Uri A. LopatinHEPATOLOGY(2017)引用 0|浏览26暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要